Generated by GPT-5-mini| VTEC | |
|---|---|
![]() Hatsukari715 · Public domain · source | |
| Name | VTEC |
| Domain | Bacteria |
| Phylum | Proteobacteria |
| Classis | Gammaproteobacteria |
| Ordo | Enterobacterales |
| Familia | Enterobacteriaceae |
| Genus | Escherichia |
VTEC VTEC is a group of Shiga toxin–producing Escherichia coli strains associated with severe gastrointestinal disease and outbreaks. First identified following investigations of hemorrhagic colitis and hemolytic uremic syndrome, VTEC has been a focus of research by institutions such as the Centers for Disease Control and Prevention, World Health Organization, and national public health agencies. Outbreaks linked to food, water, animals, and person-to-person transmission have involved settings investigated by the Food and Drug Administration, Public Health England, and academic centers like Johns Hopkins University and University of Oxford.
VTEC denotes strains of Escherichia coli producing Shiga toxins similar to those of Shigella dysenteriae type 1 implicated in outbreaks in United States, United Kingdom, Japan, and Germany. Major recognized serotypes include O157:H7 and non-O157 serogroups such as O26, O45, O103, O111, O121, and O145 that have been investigated by European Centre for Disease Prevention and Control, Centers for Disease Control and Prevention, and research groups at Harvard University and University of Cambridge. Surveillance systems like PulseNet, managed by the Centers for Disease Control and Prevention, and whole-genome sequencing initiatives at Wellcome Sanger Institute and National Institutes of Health have refined outbreak detection and source attribution.
VTEC pathogenesis centers on phage-encoded Shiga toxins (Stx1, Stx2) that inhibit ribosomal function and trigger endothelial injury, a mechanism studied by investigators at Pasteur Institute, Max Planck Institute, and Cold Spring Harbor Laboratory. Virulence factors include adhesion proteins such as intimin encoded by the eae gene characterized in work from Institut Pasteur, plasmid-encoded enterohemolysin associated with strains studied at University of Tokyo, and type III secretion system components described by teams at MIT and Stanford University. Mobile genetic elements like bacteriophages and plasmids facilitating horizontal gene transfer have been documented in publications from Rockefeller University and Sanger Institute laboratories.
Reservoirs for VTEC include ruminants—particularly cattle and sheep—documented in field studies coordinated by USDA researchers, veterinary teams at Royal Veterinary College, and agricultural departments in New Zealand and Australia. Foodborne outbreaks have been traced to undercooked ground beef investigated by the Food Safety and Inspection Service, raw milk and dairy products examined by Food Standards Agency, fresh produce such as leafy greens linked in reports by FDA, and ready-to-eat foods traced by regional public health units in Canada and Germany. Waterborne and recreational water outbreaks have involved investigations by Environmental Protection Agency and municipal health departments in cities like Chicago and London, while person-to-person spread in daycare centers and long-term care facilities has been studied by teams at University of Toronto and Karolinska Institutet.
Clinical manifestations range from mild diarrhea to bloody diarrhea and systemic complications including hemolytic uremic syndrome (HUS), with landmark clinical descriptions by investigators at Mayo Clinic, Cleveland Clinic, and pediatric centers at Great Ormond Street Hospital. Laboratory diagnosis employs culture on selective media (e.g., sorbitol-MacConkey for O157:H7) and detection of Shiga toxin genes by PCR assays developed in diagnostics laboratories at Roche Diagnostics, BioMérieux, and academic groups at University of California, San Francisco. Serologic and immunoassays used in outbreak settings have been implemented by public health laboratories in Netherlands and Sweden, while whole-genome sequencing for strain typing is routinely performed at Public Health England and national reference labs.
Clinical management emphasizes supportive care—hydration and monitoring for renal impairment—protocols refined by nephrology groups at Mount Sinai Hospital and pediatric nephrology services at Hospital for Sick Children. The role of antimicrobials is controversial because certain antibiotics may induce increased Shiga toxin release; guidance from Infectious Diseases Society of America and European Society of Clinical Microbiology and Infectious Diseases advises caution. Advanced care for HUS may require renal replacement therapy and intensive care reviewed in reports from American Society of Nephrology and Society of Critical Care Medicine. Experimental therapies, including toxin-neutralizing antibodies and receptor analogs, have been explored in trials at National Institutes of Health and biotech companies collaborating with Harvard Medical School investigators.
Prevention relies on farm-to-fork interventions promoted by World Health Organization and Food and Agriculture Organization, including good agricultural practices at operations overseen by United States Department of Agriculture and hygiene controls in slaughterhouses inspected by Food Standards Agency. Food industry measures include Hazard Analysis and Critical Control Points programs advocated by Codex Alimentarius Commission and national food safety authorities. Public health responses to outbreaks include case finding, traceback investigations, and risk communication coordinated by Centers for Disease Control and Prevention, national reference labs, and regional epidemiology units at institutions like Robert Koch Institute and Agence nationale de santé publique. Vaccination of cattle, farm biosecurity, and consumer education on cooking and raw milk risks are interventions promoted by veterinary research groups at Iowa State University and extension services in Ohio State University.
Category:Bacterial diseases